Prostate cancer is the most common cancer in men. It accounts for one-quarter of all cancers in men.
Many treatments are now available to better control the disease and improve patient survival. Among them, hormone therapy plays a key role.
Although this treatment is effective, it can sometimes cause side effects that affect daily life and quality of life. It was in this context that the “IMPAPRO” study was launched.
What is hormone therapy?
Prostate cancer develops asa result of male hormones, primarily testosterone. Hormone therapy aims to block the action of these hormones, either by reducing their production or by blocking their effect on cancer cells.
This treatment is sometimes accompanied by side effects that can be difficult to cope with: fatigue, hot flashes, joint pain, weight gain, mood swings, decreased libido, changes in body image…
These physical changes can also have psychological consequences and affect the course of treatment.
The objective of the IMPAPRO study
The primary objective of the IMPAPRO study isto evaluate the impact of a personalized care pathway focused on the physical and emotional experiences of patients undergoing hormone therapy for prostate cancer.
The study aims to determine whether enhanced support helps to: better manage side effects, boost morale and self-esteem, and improve treatment adherence.
Ultimately, this study could lead to better patient care during treatment, particularly by taking into account the patient’s physical and psychological experiences.
Support measures have been put in place
The Baclesse Center has developed a care pathway specifically designed for patients receiving hormone therapy. This program is based on a multidisciplinary approach involving several healthcare professionals.
The IMPAPRO study evaluates the benefits of additional personalized nursing care for 12 months, in addition to standard care.
Comprehensive care from the start of treatment
From the start of hormone therapy, patients meet with several healthcare professionals to receive comprehensive care.
The oncologist: prescribes treatment, provides medical follow-up, and refers patients to other specialists as needed.
The dietitian andAdapted Physical Activity(APA) instructor: They provide advice on physical activity, nutrition, and healthy living.
The care coordinator: They explain the treatment, provide information on side effects, monitor test results, and assess the patient’s needs. The various areas addressed include: pain, sleep, nutrition, physical activity, mental health, and sexuality…
A nurse specializing in oncology-related sexual health or ostomy care: they address issues related to sexuality and urinary disorders.
What participants get in addition
Patients receiving personalized care are supported for one year through regular contact with the healthcare team.
An initial phone call is scheduled to ensure that the treatment has been properly understood, to discuss any potential side effects, and to review the advice provided if necessary.
A second meeting is then organized, involving several healthcare professionals—depending on the patient’s identified needs— to provide personalized support to patients and their families as they navigate changes in their daily lives.
Questionnaires to assess quality of life
All participants complete questionnaires at the start of treatment, and then at 1, 3, 6, and 12 months.
They helpassess several important aspects, such as quality of life, anxiety, body image, the impact of cancer on daily life, and treatment follow-up.
A study focused on quality of life
This clinical trial plans to enroll between 120 and 140 participants over an estimated two-year period. With IMPAPRO, the goal is not only to treat cancer but also to better support patients in all aspects of their care.
This study could help demonstrate that regular, personalized patient follow-up helps patients cope better with their treatment, maintain a higher quality of life, and continue their care under better conditions.
